All Stories

  1. MMP inhibitors attenuate doxorubicin cardiotoxicity by preventing intracellular and extracellular matrix remodeling

    Article • Cardiovascular Research, January 2020, Oxford University Press (OUP)

    Professor Richard Schulz, Dr Consolato M. Sergi

  2. Myocardial MMP-2 contributes to SERCA2a proteolysis during cardiac ischemia-reperfusion injury

    Article • Cardiovascular Research, August 2019, Oxford University Press (OUP)

    Professor Richard Schulz

  3. Proteolytic Digestion of Serum Cardiac Troponin I as Marker of Ischemic Severity

    Article • The Journal of Applied Laboratory Medicine, February 2018, AACC

    Professor Richard Schulz, somaya zahran

  4. Multicentric osteolysis with nodulosis, arthritis, and cardiac defect syndrome: loss of MMP2 leads to increased apoptosis with alteration of apoptotic regulators and caspases and embryonic lethality

    Article • Advances in Genomics and Genetics, November 2014, Taylor & Francis

    Professor Richard Schulz

  5. Smoothelin-B is not a target of matrix metalloproteinase (MMP)-2 in the vasculature of endotoxemic rats

    Article • Canadian Journal of Physiology and Pharmacology, October 2014, Canadian Science Publishing

    Professor Richard Schulz

  6. Matrix metalloproteinases 2 and 9 as diagnostic markers in the progression to Chagas cardiomyopathy

    Article • American Heart Journal, April 2013, Elsevier

    Professor Richard Schulz

  7. Mechanisms of cytosolic targeting of matrix metalloproteinase‐2

    Article • Journal of Cellular Physiology, June 2012, Wiley

    Professor Richard Schulz